34 results
424B5
ENTX
Entera Bio Ltd.
10 Jan 25
Prospectus supplement for primary offering
4:05pm
time based on various factors such as regulatory requirements, collaboration agreements, the competitive environment and new data from pre-clinical
424B3
ssi15tkg5n6ck
15 Feb 24
Prospectus supplement
5:10pm
8-K
EX-10.1
kf1rx68mj528
26 Dec 23
Entry into a Material Definitive Agreement
8:00am
8-K
EX-10.1
n4zekc
2 Sep 22
Entry into a Material Definitive Agreement
4:05pm
8-K
EX-10.1
w9497sfkd1q wm8
18 Jul 22
Departure of Directors or Certain Officers
7:05am
S-3
EX-1.2
su2oxjno
27 May 22
Shelf registration
4:28pm
8-K
EX-10.1
hjdwaxqu
16 May 22
Departure of Directors or Certain Officers
8:00am
10-K
rk03anosp y4kpzfz
8 Mar 22
Annual report
8:30am